im cannabis - IMCC

IMCC

Close Chg Chg %
1.44 -0.05 -3.47%

Closed Market

1.39

-0.05 (3.47%)

Volume: 37.75K

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Company Overview: im cannabis - IMCC

IMCC Key Data

Open

$1.44

Day Range

1.36 - 1.45

52 Week Range

0.93 - 7.12

Market Cap

$4.44M

Shares Outstanding

3.09M

Public Float

1.71M

Beta

1.99

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.79

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

288.62K

 

IMCC Performance

1 Week
 
-2.80%
 
1 Month
 
-23.63%
 
3 Months
 
-30.15%
 
1 Year
 
-40.37%
 
5 Years
 
-99.70%
 

IMCC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About im cannabis - IMCC

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

IMCC At a Glance

IM Cannabis Corp.
Kibbutz
Glil Yam, Tel Aviv 46905
Phone 972-77-444-2333 Revenue 39.44M
Industry Agricultural Commodities/Milling Net Income -7,726,494.04
Sector Process Industries 2024 Sales Growth 9.072%
Fiscal Year-end 12 / 2025 Employees 55
View SEC Filings

IMCC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.139
Price to Book Ratio 1.973
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -4.518
Enterprise Value to Sales 0.403
Total Debt to Enterprise Value 0.788

IMCC Efficiency

Revenue/Employee 717,087.129
Income Per Employee -140,481.71
Receivables Turnover 3.401
Total Asset Turnover 1.227

IMCC Liquidity

Current Ratio 0.669
Quick Ratio 0.51
Cash Ratio 0.027

IMCC Profitability

Gross Margin 11.612
Operating Margin -12.965
Pretax Margin -23.679
Net Margin -19.591
Return on Assets -24.045
Return on Equity -105.708
Return on Total Capital -47.784
Return on Invested Capital -96.712

IMCC Capital Structure

Total Debt to Total Equity 343.544
Total Debt to Total Capital 77.454
Total Debt to Total Assets 45.963
Long-Term Debt to Equity 12.15
Long-Term Debt to Total Capital 2.739
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Im Cannabis - IMCC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
43.31M 41.74M 36.16M 39.44M
Sales Growth
+265.59% -3.63% -13.36% +9.07%
Cost of Goods Sold (COGS) incl D&A
40.85M 34.46M 31.08M 34.86M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.57M 5.63M 2.22M 1.59M
Depreciation
3.65M 3.83M 917.25K 589.07K
Amortization of Intangibles
923.64K 1.80M 1.30M 1.01M
COGS Growth
+218.50% -15.65% -9.80% +12.17%
Gross Income
2.46M 7.28M 5.08M 4.58M
Gross Income Growth
+351.45% +195.75% -30.21% -9.86%
Gross Profit Margin
+5.68% +17.44% +14.05% +11.61%
2021 2022 2023 2024 5-year trend
SG&A Expense
38.83M 27.32M 14.10M 9.69M
Research & Development
- - - -
-
Other SG&A
38.83M 27.32M 14.10M 9.69M
SGA Growth
+178.34% -29.64% -48.39% -31.26%
Other Operating Expense
- - - -
-
Unusual Expense
(18.46M) 3.61M 457.14K (145.99K)
EBIT after Unusual Expense
(17.91M) (23.65M) (9.48M) (4.97M)
Non Operating Income/Expense
4.86M 5.15M 5.19M (1.11M)
Non-Operating Interest Income
4.86M 5.15M 5.19M 1.25M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.31M 1.51M 2.72M 3.26M
Interest Expense Growth
-92.77% +15.24% +79.56% +19.86%
Gross Interest Expense
1.31M 1.51M 2.72M 3.26M
Interest Capitalized
- - - -
-
Pretax Income
(14.37M) (20.02M) (7.01M) (9.34M)
Pretax Income Growth
+32.32% -39.33% +65.00% -33.28%
Pretax Margin
-33.17% -47.96% -19.38% -23.68%
Income Tax
402.80K (874.14K) 571.24K (746.74K)
Income Tax - Current - Domestic
181.06K 516.19K 279.32K (637.24K)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
221.74K (1.39M) 291.92K (109.49K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(14.77M) (19.14M) (7.58M) (8.59M)
Minority Interest Expense
(602.20K) (1.85M) (540.87K) (865.72K)
Net Income
(14.17M) (17.29M) (7.04M) (7.73M)
Net Income Growth
+33.78% -22.05% +59.30% -9.80%
Net Margin Growth
-32.71% -41.43% -19.46% -19.59%
Extraordinaries & Discontinued Operations
- - - (127.80M)
-
Discontinued Operations
- - - (127.80M)
-
Net Income After Extraordinaries
(14.17M) (145.09M) (7.04M) (7.73M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(14.17M) (145.09M) (7.04M) (7.73M)
EPS (Basic)
-14.6658 -121.2309 -3.2938 -3.289
EPS (Basic) Growth
+55.94% -726.62% +97.28% +0.15%
Basic Shares Outstanding
966.05K 1.20M 2.14M 2.35M
EPS (Diluted)
-31.6273 -121.2309 -3.2938 -3.289
EPS (Diluted) Growth
+4.99% -283.31% +97.28% +0.15%
Diluted Shares Outstanding
996.22K 1.20M 2.14M 2.35M
EBITDA
(31.80M) (14.41M) (6.80M) (3.52M)
EBITDA Growth
-123.37% +54.68% +52.81% +48.26%
EBITDA Margin
-73.43% -34.53% -18.81% -8.92%

Snapshot

Average Recommendation HOLD Average Target Price 6.00
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate N/A
Last Quarter’s Earnings -0.535 Median PE on CY Estimate N/A
Year Ago Earnings -3.134 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A N/A N/A
Mean Estimate N/A N/A N/A N/A
High Estimates N/A N/A N/A N/A
Low Estimate N/A N/A N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Im Cannabis - IMCC

Date Name Shares Transaction Value
Jun 6, 2025 Oren Shuster N/A Exercise of warrants 0.00
Jun 6, 2025 Oren Shuster 769,507 Exercise of warrants 0.00
Jun 6, 2025 Oren Shuster N/A Acquisition or disposition under a prospectus exemption Non-derivative transaction at $2.61 per share 0.00
Jun 6, 2025 Oren Shuster 236,935 Acquisition or disposition under a prospectus exemption Non-derivative transaction at $2.61 per share 618,400.35
Jun 6, 2025 Oren Shuster N/A Exercise of warrants 0.00
Jun 6, 2025 Oren Shuster 194,110 Exercise of warrants 0.00
Jun 6, 2025 Rafael Gabay N/A Acquisition or disposition under a prospectus exemption Non-derivative transaction at $2.61 per share 0.00
Jun 6, 2025 Rafael Gabay 260,279 Acquisition or disposition under a prospectus exemption Non-derivative transaction at $2.61 per share 679,328.19

Im Cannabis in the News